← Leaderboards
Thomas D Schmittgen
Washington State University
$4,409,681
Attributed
$6,402,284
Total exposure
13
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $863.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,402,284 · 13
By mechanism
R21$1,912,355 · 6
UH3$1,631,974 · 1
UH2$1,480,302 · 1
U54$750,200 · 4
R33$627,453 · 1
Top collaborators
- Mitch A Phelps8 shared
- Fan Zhang3 shared
- Christian Jobin2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsGene ExpressionCellsIn VitroCohortMicrornasPancreasMalignant Neoplasm Of PancreasBaseGenesSamplingIncidenceLiverTechnologyEffective TherapyPharmaceutical PreparationsAcinus Organ ComponentMetaplasiaEventEvaluationEducationDuct (Organ) StructureOligonucleotidesPancreatic Ductal Adenocarcinoma
Grant awards (33)
Full Project 3 â Pancreatic ADM$117,199
U54 · FY2025 · CA · contact PI
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer$203,188
R21 · FY2024 · CA
Project 3 ADM$110,225
U54 · FY2024 · CA · contact PI
NCI Diversity Supplement$76,543
R21 · FY2024 · CA
Project 3 ADM$3,988
U54 · FY2024 · CA · contact PI
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer$178,234
R21 · FY2023 · CA
Project 3 ADM$116,025
U54 · FY2023 · CA · contact PI
Modulation of microbiome function by host-derived noncoding small RNA$188,420
R21 · FY2022 · AI
Modulation of microbiome function by host-derived noncoding small RNA$226,545
R21 · FY2021 · AI
Pilot Project 3: Contribution of Racial Disparity towards the Early Development of Pancreatic Cancer$112,953
U54 · FY2020 · CA · contact PI
Pilot Project 3: Contribution of Racial Disparity towards the Early Development of Pancreatic Cancer$89,664
U54 · FY2019 · CA · contact PI
Pilot Project$22,344
U54 · FY2019 · CA · contact PI
Pilot Project 3: Contribution of Racial Disparity towards the Early Development of Pancreatic Cancer$21,795
U54 · FY2019 · CA · contact PI
Pilot Project 3: Contribution of Racial Disparity towards the Early Development of Pancreatic Cancer$96,845
U54 · FY2018 · CA · contact PI
Contribution of Racial Disparity Towards the Early Development of Pancreatic Cancer$33,457
U54 · FY2018 · CA · contact PI
Pilot Project$25,705
U54 · FY2018 · CA · contact PI
Targeted delivery of microRNA-loaded microvesicle for cancer therapy$768,797
UH3 · FY2017 · TR · contact PI
Targeted delivery of microRNA-loaded microvesicle for cancer therapy$800,677
UH3 · FY2016 · TR · contact PI
Targeted delivery of microRNA-loaded microvesicle for cancer therapy$62,500
UH3 · FY2016 · TR · contact PI
Targeted delivery of microRNA-loaded microvesicle for cancer therapy$380,094
UH2 · FY2015 · TR · contact PI
Targeted delivery of microRNA-loaded microvesicle for cancer therapy$50,000
UH2 · FY2015 · TR · contact PI
Targeted delivery of microRNA-loaded microvesicle for cancer therapy$487,017
UH2 · FY2014 · TR · contact PI
Targeted delivery of microRNA-loaded microvesicle for cancer therapy$63,192
UH2 · FY2014 · TR · contact PI
Targeted delivery of microRNA-loaded microvesicle for cancer therapy$499,999
UH2 · FY2013 · TR · contact PI
miRNA Biomarkers for Hepatocellular Carcinoma Associated with Viral Hepatitis$167,657
R21 · FY2013 · CA · contact PI
miRNA Biomarkers for Hepatocellular Carcinoma Associated with Viral Hepatitis$250,966
R21 · FY2012 · CA · contact PI
Real-time PCR expression profiling of microRNA$209,130
R33 · FY2010 · CA · contact PI
Real-time PCR expression profiling of microRNA$209,151
R33 · FY2009 · CA · contact PI
Real-time PCR expression profiling of microRNA$209,172
R33 · FY2008 · CA · contact PI
Real-time PCR expression profiling of microRNA$210,183
R21 · FY2006 · CA · contact PI
Micro RNA Expression and Cancer$134,550
R21 · FY2005 · CA
Micro RNA Expression and Cancer$134,550
R21 · FY2004 · CA
APTAMERS AS CELLULAR TARGETING AGENTS$141,519
R21 · FY2000 · CA